Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 12 October 2026 ASX Announcement Firebrick Secures $732k in Strategic Investments Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to...
Firebrick Secures $732k in Strategic Investments
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The investment includes significant contributions from its licensing partner in the Philippines, Pharma Nutria N.A. Inc., and an existing investor. Proceeds from the placement will be used for new production for US retail distribution, launching a new product in Singapore, and working capital.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Firebrick announces USA Retail Launch Plan
- Firebrick receives $293,000 R&D Tax Incentive
- Appendix 4E and Annual Report 30 June 2026
- Investor Update
- March 2026 Quarterly Activity Report & Appendix 4C
Later from Firebrick Pharma
All Firebrick Pharma news releasesFollow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma